QRONS

Qrons is a publicly-traded, preclinical biotechnology company that develops advanced cell-based solutions to combat neurological injuries. While they are laser-focused on traumatic brain injury (TBI), their technology could potentially treat a wide range of neurodegenerative diseases. Their TBI treatment integrates proprietary, engineered mesenchymal stem cells (MSCs), 3D printable scaffolding, smart materials, and a novel delivery system. They believe this combination will reduce neuronal loss and functional impairment and possibly regenerate brain tissue and function for TBI patients. It was founded in 2016 and is headquartered in New York, New York.